Eb Group Sp. z o.o.

At Centrum Zdrowia MDM in Warsaw, much of the clinical trial activity centers on gastroenterology and immune system diseases, especially Crohn’s disease and ulcerative colitis. These studies are mainly designed to test new therapies, compare treatment options, and better understand long-term control of chronic intestinal inflammation.

• Clinical remission and symptom improvement in Crohn’s disease and ulcerative colitis
• Maintenance of response and long-term safety in inflammatory bowel disease
• Evaluation of new immune-targeted treatments for moderate to severe disease

The research portfolio also includes studies looking at endoscopic improvement and overall treatment effectiveness, reflecting a strong focus on both patient-reported outcomes and objective disease control.

This site also supports research in eye diseases and hormonal diseases, with trials in thyroid eye disease, Graves’ disease, neovascular age-related macular degeneration, and center-involved diabetic macular edema. The main goal is to evaluate new treatments that may reduce inflammation, improve vision-related outcomes, and address disease-related eye changes.

• Therapies for thyroid eye disease and Graves’ disease
• Treatment studies in diabetic macular edema and wet AMD
• Assessment of visual benefit and disease control

The trial landscape shows a broad interest in both autoimmune eye conditions and retinal diseases, combining efforts to improve symptoms, preserve vision, and expand treatment options.

Clinical research at Eb Group Sp. z o.o. also extends to other digestive system diseases, including eosinophilic esophagitis and related inflammatory conditions. These studies are focused on testing whether targeted therapies can reduce tissue inflammation, ease swallowing problems, and improve daily functioning for people with chronic esophageal disease.

• Eosinophilic esophagitis and upper digestive tract inflammation
• Studies of symptom relief and histologic improvement
• Evaluation of long-term safety and tolerability

By including both short-term and extended follow-up research, the site contributes to a better understanding of how emerging treatments may help patients with persistent inflammatory digestive disorders.

Beyond gastrointestinal and eye conditions, the site participates in studies across immune system phenomena, respiratory tract diseases, and selected rare disorders such as spinal muscular atrophy, focal segmental glomerulosclerosis, congenital adrenal hyperplasia, and hypoparathyroidism. These trials generally aim to assess whether new therapies can improve disease control, reduce symptoms, or support safer long-term management.

• Rare disease studies in endocrine, neuromuscular, and kidney conditions
• Respiratory research in chronic rhinosinusitis without nasal polyps
• Immune-focused trials exploring targeted treatment approaches

The broader portfolio indicates that the Warsaw site is engaged in a diverse range of clinical research, with a clear emphasis on chronic inflammatory disease and carefully selected rare conditions.